Atlas Trials

Safety and Efficacy of Evolocumab in Ischemic Stroke

Clinical trial NCT05697185 · UNKNOWN

Trial details

NCT number
NCT05697185
Sponsor
Second Affiliated Hospital of Guangxi Medical University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Ischemic Stroke, Acute
Start date
2023-02-01
Primary completion
2024-02-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.